Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Bibliographic Details
Main Authors: Yamanaka, Hisashi, Tanaka, Yoshiya, Takeuchi, Tsutomu, Sugiyama, Naonobu, Yuasa, Hirotoshi, Toyoizumi, Shigeyuki, Morishima, Yosuke, Hirose, Tomohiro, Zwillich, Samuel
Format: Online
Language:English
Published: BioMed Central 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730592/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730592/

Similar Items